Formylated Peptide Receptor-1-Mediated Gut Inflammation as a Therapeutic Target in Inflammatory Bowel Disease.

Autor: McAllister MJ; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Hall R; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Whelan RJ; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Fischer LJ; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Chuah CS; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Cartlidge PD; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Drury B; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Rutherford DG; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Duffin RM; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Cartwright JA; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Dorward DA; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Rossi AG; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK., Ho GT; Edinburgh IBD Science Unit, Centre for Inflammation Research, Queens Medical Research Unit, University of Edinburgh, Edinburgh, Scotland, UK.

Publikováno v: Crohn's & colitis 360 [Crohns Colitis 360] 2024 Jan 12; Vol. 6 (1), pp. otae003. Date of Electronic Publication: 2024 Jan 12 (Print Publication: 2024).

Neutrophil-dependent Mitochondrial DNA Release Associated With Extracellular Trap Formation in Inflammatory Bowel Disease.

Autor: Drury B; Edinburgh IBD Science Unit, Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK., Chuah CS; Edinburgh IBD Science Unit, Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK., Hall R; Edinburgh IBD Science Unit, Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK., Hardisty GR; Edinburgh IBD Science Unit, Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK., Rossi AG; Edinburgh IBD Science Unit, Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK., Ho GT; Edinburgh IBD Science Unit, Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.

Publikováno v: Gastro hep advances [Gastro Hep Adv] 2023 Mar 23; Vol. 2 (6), pp. 788-798. Date of Electronic Publication: 2023 Mar 23 (Print Publication: 2023).

Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding-long-term follow-up of a randomised control trial.

Autor: Dunne PDJ; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Young D; Department of Statistics, Strathclyde University, Glasgow, UK., Chuah CS; Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK., Hayes PC; Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK.; University of Edinburgh, Edinburgh, UK., Tripathi D; Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK.; Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Leithead J; Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK.; Forth Valley Royal Hospital, UK., Smith LA; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Gaya DR; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK.; University of Glasgow, Glasgow, UK., Forrest E; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK.; University of Glasgow, Glasgow, UK., Stanley AJ; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK.; University of Glasgow, Glasgow, UK.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Jun; Vol. 55 (12), pp. 1581-1587. Date of Electronic Publication: 2022 Mar 24.

Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort.

Autor: Plevris N; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Fulforth J; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Siakavellas S; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Robertson A; Department of Gastroenterology, University Hospital Hairmyres, East Kilbride, UK., Hall R; Department of Gastroenterology, Ninewells Hospital, Dundee, UK., Tyler A; Department of Gastroenterology, Raigmore Hospital, Inverness, UK., Jenkinson PW; Department of Gastroenterology, Raigmore Hospital, Inverness, UK., Campbell I; Department of Gastroenterology, Royal Alexandra Hospital, Paisley, UK., Chuah CS; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.; Department of Gastroenterology, Victoria Hospital, Kirkcaldy, UK., Kane C; Department of Gastroenterology, Aberdeen Royal Infirmary, Aberdeen, UK., Veryan J; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Lam WL; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Saunders J; Department of Gastroenterology, University Hospital Hairmyres, East Kilbride, UK., Kelly C; Department of Gastroenterology, Forth Valley Royal Hospital, Larbert, UK., Gaya D; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Jafferbhoy H; Department of Gastroenterology, Victoria Hospital, Kirkcaldy, UK., Macdonald JC; Department of Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK., Seenan JP; Department of Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK., Mowat C; Department of Gastroenterology, Ninewells Hospital, Dundee, UK., Naismith G; Department of Gastroenterology, Royal Alexandra Hospital, Paisley, UK., Potts LF; Department of Gastroenterology, Raigmore Hospital, Inverness, UK., Sutherland DI; Department of Gastroenterology, University Hospital Hairmyres, East Kilbride, UK., Watts D; Department of Gastroenterology, Forth Valley Royal Hospital, Larbert, UK., Arnott I; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Bain G; Department of Gastroenterology, Aberdeen Royal Infirmary, Aberdeen, UK., Jones G; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Lees CW; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Publikováno v: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2021 Aug; Vol. 36 (8), pp. 2067-2075. Date of Electronic Publication: 2021 Mar 05.

Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort.

Autor: Plevris N; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Chuah CS; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Allen RM; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Arnott ID; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Brennan PN; Department of Gastroenterology, Ninewells Hospital, Dundee, UK., Chaudhary S; Department of Gastroenterology, University Hospital Hairmyres, East Kilbride, UK., Churchhouse AMD; Department of Gastroenterology, Victoria Hospital, Kirkcaldy, UK., Din S; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Donoghue E; Department of Gastroenterology, Forth Valley Royal Hospital, Larbert, UK., Gaya DR; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Groome M; Department of Gastroenterology, Ninewells Hospital, Dundee, UK., Jafferbhoy HM; Department of Gastroenterology, Victoria Hospital, Kirkcaldy, UK., Jenkinson PW; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.; Department of Colorectal Surgery, Raigmore Hospital, Inverness, UK., Lam WL; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Lyons M; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Macdonald JC; Department of Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK., MacMaster M; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Mowat C; Department of Gastroenterology, Ninewells Hospital, Dundee, UK., Naismith GD; Department of Gastroenterology, Royal Alexandra Hospital, Paisley, UK., Potts LF; Department of Gastroenterology, Raigmore Hospital, Inverness, UK., Saffouri E; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Seenan JP; Department of Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK., Sengupta A; Department of Gastroenterology, Victoria Hospital, Kirkcaldy, UK., Shasi P; Department of Gastroenterology, Ninewells Hospital, Dundee, UK., Sutherland DI; Department of Gastroenterology, University Hospital Hairmyres, East Kilbride, UK., Todd JA; Department of Gastroenterology, Ninewells Hospital, Dundee, UK., Veryan J; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Watson AJM; Department of Colorectal Surgery, Raigmore Hospital, Inverness, UK., Watts DA; Department of Gastroenterology, Forth Valley Royal Hospital, Larbert, UK., Jones GR; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Lees CW; The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.

Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2019 Sep 19; Vol. 13 (9), pp. 1111-1120.